Cas No.: 1228992-90-2
PRODUCT INFORMATION
Description
Cyclo(RGDfK(Mal)) is a maleimide-modified cyclic pentapeptide designed to mimic extracellular matrix interactions, thereby enhancing cellular adhesion. Its RGD motif targets integrins, while the maleimide group allows for covalent conjugation. It is a critical component for functionalizing advanced 3D biomaterial scaffolds, enabling scalable stem cell culture and controlled expansion under physiologically relevant in vitro conditions.
Molecular Weight
754.79
Purity
> 95%
Formula
C₃₄H₄₆N₁₀O₁₀
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Lys(MAL)]
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Tyr-Somatostatin-14 Targeting Peptide (CAT#: OLY-1025-YS-63)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
- HER2-targeted Peptide H6F (CAT#: OLY-1025-YS-5)
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- Octreotide Pamoate Targeting Peptide (CAT#: OLY-1025-YS-4)
- Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) Targeting Peptide (CAT#: OLY-1025-YS-62)
- F3 Targeting Peptide (CAT#: OLY-1025-YS-28)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.